US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 1.250
  • -0.100-7.41%
Close Dec 12 16:00 ET
106.29MMarket Cap-0.68P/E (TTM)

Century Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Century Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 633.330K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 633.330K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--

Unlock Free Earnings Estimates

Century Therapeutics Earnings Reports

  • Century Therapeutics | 8-K: Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 5 09:11 ET

  • Century Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 09:11 ET

  • Century Therapeutics | 8-K: Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 8 07:39 ET

  • Century Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:34 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data